project id: TCGA-STAD; case submitter id: TCGA-IN-A6RP; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.96; rna integrity number: 7.2; age at index: 63; days to birth: -23282; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 23282; ajcc pathologic m: M0; ajcc pathologic n: N3; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 196.0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: No; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; initial weight: 210.0; sample id: 4079f262-997b-4b55-8b96-5a0643cb9760; sample submitter id: TCGA-IN-A6RP-01A; portion id: 31cff1eb-f3fe-4f82-82b8-7c76b0a9ed10; portion submitter id: TCGA-IN-A6RP-01A-21; slide id: 1dddb5b4-9e8e-4e7d-86db-59be3f4bfd10; slide submitter id: TCGA-IN-A6RP-01A-02-TSB; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 2.0; percent necrosis: 1.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 24.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; section location: TOP;